Single and multiple oral doses of LGD-4665, a small molecule thrombopoietin receptor agonist, increase platelet counts in healthy male subjects

被引:8
|
作者
Dziewanowska, Zofia E. [1 ]
Matsumoto, Richard M. [1 ]
Zhang, J. K. [1 ]
Schindler, Kristine [1 ]
Loewen, Gordon [1 ]
Doherty, James P. [2 ]
Berg, Jolene K. [2 ]
Newberry, Barbara [2 ]
机构
[1] Clin Res Ligand Pharmaceut Inc, San Diego, CA USA
[2] CEDRA Clin Res, San Antonio, TX USA
关键词
D O I
10.1182/blood.V110.11.1298.1298
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1298
引用
收藏
页码:390A / 390A
页数:1
相关论文
共 37 条
  • [1] SINGLE AND MULTIPLE ORAL DOSES OF LGD-4665, A SMALL MOLECULE THROMBOPOIETIN RECEPTOR AGONIST, INCREASE PLATELET COUNTS IN HEALTHY MALE SUBJECTS AND DEMONSTRATE POTENTIAL TO TREAT THROMBOCYTOPENIC PATIENTS
    Dziewanowska, E.
    Zhang, J.
    Kapil, P.
    Greenberg, G.
    Matsumoto, M.
    Schindler, J.
    Berg, J.
    Newberry, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 377 - 378
  • [2] SB-497115, a novel, oral, small molecule thrombopoietin receptor agonist, increases platelet counts in healthy subjects
    Jenkins, JM
    Williams, D
    Collins, DA
    Deng, Y
    Kitchen, V
    Erickson-Miller, C
    EXPERIMENTAL HEMATOLOGY, 2005, 33 (07) : 64 - 65
  • [3] An oral, non-petide, small molecule thrombopoietin receptor agonist increases platelet counts in healthy subjects.
    Jenkins, J
    Nicholl, R
    Williams, D
    Baidoo, C
    Phillips, J
    Deng, YL
    Kitchen, V
    Erickson-Miller, C
    BLOOD, 2004, 104 (11) : 797A - 797A
  • [4] Clinical Characterization of a Novel Oral Thrombopoietin Mimetic LGD-4665 in Healthy Volunteers Demonstrate Safe and Sustained Increases in Platelet Counts with Flexible Dosing Choices for Phase II Trials
    Dziewanowska, Zofia E.
    Kapil, Ram P.
    Zhang, J. K.
    Berg, Jolene K.
    Stevens, Victor J.
    Matsumoto, Richard M.
    Greenberg, Lisa
    Morris, Maryanna Y.
    BLOOD, 2008, 112 (11) : 1168 - 1168
  • [5] Pharmacokinetics and pharmacodynamics of single and multiple doses of the glucagon receptor antagonist LGD-6972 in healthy subjects and subjects with type 2 diabetes mellitus
    Vajda, Eric G.
    Logan, Douglas
    Lasseter, Kenneth
    Armas, Danielle
    Plotkin, Diane J.
    Pipkin, J. D.
    Li, Yong-Xi
    Zhou, Rong
    Klein, David
    Wei, Xiaoxiong
    Dilzer, Stacy
    Zhi, Lin
    Marschke, Keith B.
    DIABETES OBESITY & METABOLISM, 2017, 19 (01): : 24 - 32
  • [6] Single and multiple oral doses of AKR-501 (YM477) increase the platelet count in healthy volunteers.
    Desjardins, Robert E.
    Tempel, Donna L.
    Lucek, Rudolph
    Kuter, David J.
    BLOOD, 2006, 108 (11) : 145A - 145A
  • [7] PHARMACOKINETICS AND TOLERABILITY OF THE ORAL SELECTIVE PROSTACYCLIN RECEPTOR AGONIST SELEXIPAG AFTER MULTIPLE-DOSE ADMINISTRATION IN HEALTHY MALE SUBJECTS
    Kaufmann, P.
    Okubo, K.
    Sidharta, P.
    Mant, T.
    Dingemanse, J.
    Mukai, H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S88 - S89
  • [8] Pharmacokinetics, Safety and Tolerability of Single and Multiple Doses of TAK-875, a Novel GPR40 Agonist, in Japanese Healthy Male Subjects
    Matsuno, Kumi
    Hirayama, Masashi
    Araki, Takahiro
    Dote, Nobuhito
    Kondo, Takahiro
    Nakamura, Koki
    DIABETES, 2010, 59 : A193 - A193
  • [9] Safety, Tolerability and Pharmacokinetics of Vidofludimus calcium (IMU-838) After Single and Multiple Ascending Oral Doses in Healthy Male Subjects
    Muehler, Andreas
    Kohlhof, Hella
    Groeppel, Manfred
    Vitt, Daniel
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2020, 45 (05) : 557 - 573
  • [10] Safety, Tolerability and Pharmacokinetics of Vidofludimus calcium (IMU-838) After Single and Multiple Ascending Oral Doses in Healthy Male Subjects
    Andreas Muehler
    Hella Kohlhof
    Manfred Groeppel
    Daniel Vitt
    European Journal of Drug Metabolism and Pharmacokinetics, 2020, 45 : 557 - 573